AbstractBySubCategory

Novel Biomarker Approaches

Biomarkers and Inflammatory Signatures

2017 ASCO-SITC Clinical Immuno-Oncology Symposium

ABSTRACT TITLE FIRST AUTHOR ABSTRACT NO.sort descending
Diagnostic accuracy of molecular tumor profiling in determining the tissue of origin in adult patients with cancer of unknown primary: A meta-analysis. Rowena Torres Inocencio

20

Prognostic value of CD8+ tumor-infiltrating lymphocyte density and PD-L1 expression in tumor cells in thymic epithelial tumors. Yuki Katsuya

21

Development of DDPCR blood-based diagnostic tests that simultaneously measure mRNA expression from immune and cancer cells. Hestia S. Mellert

22

Correlation of T-cell infiltration and clonality with PD-L1 expression in soft tissue sarcomas. Seth Pollack

23

Association of tumor mutational burden with smoking and mutation status in non-small cell lung cancer (NSCLC). Andrew A. Davis

24

Effect of RELT on regulation of the threshold of T-cell activation during sterile inflammation. Seon-Hee Kim

25

Immune profiling of circulating T cells and TILs following neoadjuvant ipilimumab and chemotherapy in non-small cell lung cancer (NSCLC). John Yi

26

A new approach for immuno-oncology biomarker discovery: High-plex, spatial protein profiling based on NanoString digital quantification. David Lee

27

HER2 gene amplification and protein overexpression in uterine clear cell carcinoma and its implications in targeted immunotherapy. Jain Zhou

29

Identifying treatment options for triple negative breast cancer patients using RNA-sequencing. Gitte Pedersen

31

Transcripts of immune cell surface proteins from tumor samples to predict patient clinical outcome. Aiwu Ruth He

32